Retrospective review of serotonergic medication tolerability in patients with neuroendocrine tumors with biochemically proven carcinoid syndrome
暂无分享,去创建一个
I. Braun | M. Kulke | S. Minden | L. Brais | F. Meyer | J. Chan | Diana D. Shi | D. P. Yuppa | Trevor Dutton
[1] J. Wills,et al. Retrospective Chart Review of Antidepressant Use in Patients with Carcinoid Tumors , 2017 .
[2] Virginia A. Sadock,et al. Kaplan and Sadock's Comprehensive Textbook of Psychiatry , 2017 .
[3] R. S. Longman,et al. Cognitive Impairment Associated With Carcinoid Syndrome , 2014, Annals of surgery.
[4] vaishali patel,et al. Article title with , 2013 .
[5] R. S. Longman,et al. Impairment of Cognitive Function Reported by Patients Suffering from Carcinoid Syndrome , 2010, World Journal of Surgery.
[6] David Gross,et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical Markers , 2009, Neuroendocrinology.
[7] H. Boezen,et al. Sexual Function in Patients with Metastatic Midgut Carcinoid Tumours , 2008, Neuroendocrinology.
[8] A. Mee,et al. Carcinoid syndrome unmasked by fluoxetine, a selective serotonin reuptake inhibitor. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[9] Suzanne R. Smith,et al. Depression and Antidepressant Use in Gastrointestinal Carcinoid Cancer Patients1 , 2007 .
[10] L. von Essen,et al. Health related quality of life and psychosocial function among patients with carcinoid tumours. A longitudinal, prospective, and comparative study , 2007, Health and quality of life outcomes.
[11] Mark D. Williams,et al. Selective serotonin reuptake inhibitors and patients with carcinoid tumor. , 2005, Psychosomatics.
[12] R. Balon,et al. Carcinoid tumor, selective serotonin reuptake inhibitors, and diarrhea. , 2005, Psychosomatics.
[13] J. Ajani,et al. Carcinoid A Comprehensive Review , 2003, Acta oncologica.
[14] J. A. Boer,et al. Neuropsychological investigation into the carcinoid syndrome , 2003, Psychopharmacology.
[15] L. Price,et al. Acute changes in Cerebrospinal Fluid 5-HIAA following Oral Paroxetine Challenge in Healthy Humans , 2003, Neuropsychopharmacology.
[16] L. von Essen,et al. Health-related Quality of Life, Anxiety and Depression in Patients with Midgut Carcinoid Tumours , 2001, Acta oncologica.
[17] A. Burroughs,et al. Carcinoid tumour. , 1998, Lancet.
[18] C. Noyer,et al. Sertraline, a selective serotonin reuptake inhibitor, unmasking carcinoid syndrome. , 1997, The American journal of gastroenterology.
[19] S. Sjöblom. Clinical presentation and prognosis of gastrointestinal carcinoid tumours. , 1988, Scandinavian journal of gastroenterology.
[20] J. Posner,et al. Neurologic complications of carcinoid , 1986, Neurology.
[21] W. Gunn. Cancer: Principles and Practice of Oncology , 1982 .
[22] Major Lf,et al. Carcinoid and psychiatric symptoms. , 1973 .